The company said its Q3 2024 net sales rose 4% from a year earlier, while net sales for the first 9 months of 2024 fell 2%. It attributed the 9-month sales decline to customers delaying purchases of instrument systems during the first half.

1. 01

   The company said its Q3 2024 net sales rose 4% from a year earlier, while net sales for the first 9 months of 2024 fell 2%. It attributed the 9-month sales decline to customers delaying purchases of instrument systems during the first half.

2. 02

   The company said instrument system sales rose 1% in Q3 and fell 11% over the first 9 months. It also said recurring revenue, which combines precision chemistry consumables and services, grew 6% in Q3 and 5% over the first 9 months.

3. 03

   Waters said operating income rose 18% in Q3 and fell 3% over the first 9 months. The company cited higher sales volume and cost savings from workforce reductions as factors in the Q3 increase, and said it had incurred severance-related costs of $23 million in Q3 of the prior year.

4. 04

   The company said operating cash flow in the first 9 months of 2024 rose to $522 million from $373 million a year earlier. It said total debt was $1.8 billion as of September 28, 2024, and that net debt decreased by $530 million over the first 9 months.

Key figures

Quarter ended September 28, 2024

Revenue

$740M

Operating income

$211M

EPS

$2.71

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.